ArticleCurrent oncology (Toronto, Ont.)2007

Addition of lenalidomide to melphalan in the treatment of newly diagnosed multiple myeloma: the National Cancer Institute of Canada Clinical Trials Group MY.11 trial.

D J White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.